Semaglutide is a peptide (a small protein) that activates specific metabolic pathways in your body to enhance blood sugar metabolism and reduce appetite. Semaglutide is available commercially as several FDA-approved medications: Ozempic, Rybelsus, and Wegovy. The first two are FDA approved for diabetics whose blood sugar is not yet controlled, and Wegovy is FDA approved for the treatment of obesity.
How does Semaglutide induce weight loss?
Semaglutide helps individuals with weight loss through an added-on hormone response to someone’s insulin release, interconnecting with high blood sugar. This response gives you a reduced appetite, positive body response, and ultimately loss of weight – in a healthy way! In simple, laid out terms, Semaglutide is also able to help with:
- ☑ The feeling of fullness and satisfaction from smaller meals
- ☑ More controlled and stable blood sugar levels
- ☑ Insulin secretion through the pancreas
Semaglutide is best combined with a trained supervisor who can help you track your food consumption and exercise journey. Incorporating both will enhance the effectiveness of Semaglutide and help you notice a change in your body weight more quickly!
On average, a trial of people was able to lose over 15% of their starting body weight from using Semaglutide alone in around 15 months. Because the treatment made it easy for people to engage in a caloric deficit, where people consumed fewer calories than burned, it was an effective and safe method to gradually lose weight over time.